Trainline Upgrades FullYear Guidance for Second Time This Year Este Lauder Halts Merger Talks with Puig as Charlotte Tilbury Compensation Becomes Sticking Point VolitionRx Limited VNRX Gains Attention as TopRated Penny Stock Amid Wall Street Analyst Optimism Canada and Germany Finalize First LNG Supply Agreement Sirma Group Holding AD Reports Strong Profitability Growth in Q1 2026 US April Payrolls Surge Beyond Expectations Yet Underlying Weaknesses Emerge DCTH Q1 2026 Earnings NarrowerThanExpected Loss Bolstered by Cost Discipline GFS Q1 2026 Earnings EPS Surpasses Estimates but Stock Declines on Broader Concerns MX Q1 2026 Earnings Strong EPS Beat Provides Some Relief as Revenue Picture Remains Opaque CRMD Q1 2026 Earnings Profit Surge Driven by NonOperating Items Revenue Remains Absent STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances MIND Technology Q1 2026 Earnings EPS Misses Estimates Significantly Stock Edges Higher Halliburton HAL Slips Amidst Energy Sector Headwinds Key Support Levels in Focus Moleculin Biotech MBRX Holds Steady at 273 Amid Consolidation Phase Central Securities Corporation CET Edges Higher Approaching Resistance in a Steady Advance IonQ IONQ Gains Ground as Quantum Computing Stock Approaches Key Resistance Adicet Bio ACET Edges Higher Modest Gain Amid Key Support and Resistance Levels Big Techs AI Data Centers Spark Power Crisis for 49000 California Homes WLFC Q1 2026 Earnings EPS Surges 35 Above Estimates Powered by Strong Lease Demand Uber Technologies UBER Faces Pressure as Shares Dip to 7259 Testing Key Support Levels Korea Electric Power Corporation KEP Tests Support Zone as Shares Edge Lower JFB Construction Holdings JFB Gains 318 as Shares Test Resistance Near 580 York Water Company YORW Edges Higher as Defensive Utility Appeal Drives Steady Trading Franklin Universal Trust FT Edges Higher as Mixed Signals Persist Seadrill SDRL Faces Headwinds Shares Slide 3 Amid Sector Pressure V2X Inc VVX Surges 432 Key Levels to Watch After the Breakout Alnylam Pharmaceuticals ALNY Gains 319 as Biotech Sector Momentum Builds